000			01210 a2200337 4500
005			20250513222946.0
264		0	_c20001107
008			200011s 0 0 eng d
022			_a0028-0836
024	7		_a10.1038/35037747 _2doi
040			_aNLM _beng _cNLM
100	1		_aNicholson, D W
245	0	0	_aFrom bench to clinic with apoptosis-based therapeutic agents. _h[electronic resource]
260			_bNature _cOct 2000
300			_a810-6 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aApoptosis Regulatory Proteins
650	0	4	_aCaspase Inhibitors
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aForecasting
650	0	4	_aHumans
650	0	4	_aMembrane Glycoproteins _xtherapeutic use
650	0	4	_aOligonucleotides, Antisense _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors
650	0	4	_aTNF-Related Apoptosis-Inducing Ligand
650	0	4	_aTumor Necrosis Factor-alpha _xtherapeutic use
773	0		_tNature _gvol. 407 _gno. 6805 _gp. 810-6
856	4	0	_uhttps://doi.org/10.1038/35037747 _zAvailable from publisher's website
999			_c10991978 _d10991978